A preventive prophylaxis policy has been introduced to prevent the M. tuberculosis infected population, as determined by the tuberculin skin test (TST) or an interferon gamma release assay (IGRA), from progressing to active TB. This evidence concerns the gene IFNG and tuberculosis.